News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Naveen Pemmaraju: New Collaborative Article on TET2 Mutations and Survival Benefits in Leukemia Journal
Naveen Pemmaraju/mdanderson.org
Jul 3, 2025, 17:15

Naveen Pemmaraju: New Collaborative Article on TET2 Mutations and Survival Benefits in Leukemia Journal

Naveen Pemmaraju, Professor, Department of Leukemia at MD Anderson Cancer Center, shared on X:

“Delighted to share our new collaborative article in Leukemia Journal led by Mrinal Patnaik, Guillermo Montalban-Bravo and Eric Padron.”

Title: Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes

Authors: Clifford M. Csizmar, Anuya Natu, Mark Gurney, Saubia Fathima, Ali Khalid A. Alsugair, Rashmi Kanagal-Shamanna, Sanam Loghavi, Alexandre Bazinet, Kelly Chien, Danielle Hammond, Courtney DiNardo, Tapan Kadia, Farhad Ravandi-Kashani, Naveen Pemmaraju, Koji Sasaki, Terra L. Lasho, Christy M. Finke, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Naseema Gangat, Mehrdad Hefazi Torghabeh, Aasiya Matin, Abhishek A. Mangaonkar, Mrinal M. Patnaik

Read the Full Article.

Naveen Pemmaraju

Aasiya Matin Abhishek A Mangaonkar Alexandre Bazinet Ali Khalid A. Alsugair Anuya Natu Aref Al-Kali cancer Christy M Finke Clifford M Csizmar Courtney DiNardo Danielle Hammond Eric Padron Farhad Ravandi-Kashani Guillermo Montalban-Bravo Hassan Alkhateeb Kebede Begna Kelly Chien Koji Sasaki Leukemia Journal Mark Gurney Mehrdad Hefazi Torghabeh Mrinal M Patnaik Mrinal Patnaik Naseema Gangat Naveen Pemmaraju OncoDaily Oncology Rashmi Kanagal-Shamanna Sanam Loghavi Saubia Fathima Tapan Kadia Terra L Lasho
Special Coverage
Science
Aug 19, 2025, 12:48
Luis Moreno Sánchez Highlights SBRT Study for Bladder Cancer
Blog Posts
Aug 19, 2025, 12:38
Benjamin Ebert: Looking Forward to Joining the WEEI Sports Radio Network/NESN Jimmy Fund Radio-Telethon 
Societies
Aug 19, 2025, 12:34
Safety and Radiosensitization of Olaparib with Radiotherapy in Triple-Negative Breast Cancer - ESTRO
Science
Aug 19, 2025, 12:28
John Fesko Reflects on IMvigor011 Bladder Cancer Trial 
Insight
Aug 19, 2025, 12:18
St. Jude Children's Research Hospital Highlights Biomedical Training Programs
Societies
Aug 19, 2025, 12:03
The Power of "Love and Trust" - CANCaRe Africa
Immune Oncology
Aug 19, 2025, 11:58
DANTE Trial: Phase III Recruitment Completed in Gastric and GEJ Cancer
Voices
Aug 19, 2025, 11:37
Ryan Nipp Shared G-oncoCOACH Trial Results
Voices
Aug 19, 2025, 11:32
Liz O'Riordan: Debunking Fears About Covid and Lung Metastases in Breast Cancer
Opinion
Aug 19, 2025, 11:21
Pam Traxel: The Best Way to Fight Cancer is to Detect it Early
Voices
Aug 19, 2025, 11:12
Diana Romero and Giulia Pacchioni Raising Awareness on Journal Scams to Protect Researchers
Voices
Aug 19, 2025, 11:08
Maria Babak: Thrilled to Have Dr. Kirill Kriukov Join Our Research Team